Third, the combination of PCSK9 inhibitors and Rapamycin could enhance the inhibition of the STAT3 signaling pathway, promote apoptosis, and reduce the potential proliferation and metastatic ability of malignant tumors. The gene discussed is STAT3; the disease is cancer.